A recent study by the Centre for Cell Therapy (CTC) reveals proteins and signalling pathways that are crucial to the effectiveness of CAR-T cells, opening up […]

The director of the ISCIII, Marina Pollán, and the president of Farmaindustria, Fina Lladós, have signed a General Action Protocol to promote research, innovation and knowledge […]

The Pharmaceutical R&D Survey 2024 reflects a steady increase in investment in clinical research over the last decade, which has grown at 7% per year. Direct […]

The XVIII Conference of Biomedical Research Technology Platforms brings together in Madrid more than 200 representatives from public administrations, regulatory agencies, universities and companies to analyse […]

Nathalie Moll (EFPIA) warns in an interview with Health35 that the lack of regulatory consistency and proposed environmental changes threaten investment in biomedical R&D in Europe. […]

In order to host the studies, the centres must have the resources and infrastructure. Gregorio Marañón, La Paz, Clínic de Barcelona and Vall d’Hebron are some […]

Farmaindustria presents improvements to the Draft Medicines Bill to prepare healthcare for innovation in the next 20 yearsThe future law should promote greater investment in healthcare, […]

“It is essential to see medicines and healthcare as an economically and socially very profitable investment for Spain. An investment that generates very important benefits in […]

eleconomista.es In 2023, Spain overtook Germany as the country that initiated the most clinical trials and became the European leader. This is reflected in the report […]

Joint position on the Draft Bill on Medicines and Health ProductsThe proposed system of price regulation for off-patent medicines puts at risk the supply of medicines […]

The International Federation of Innovative Pharmaceutical Industries indicates that the sector invests almost 30% of its revenues in R&D, amounting to nearly 270 billion euros. Diarofarma.com […]

The Regional Minister of Health of Cantabria, César Pascual, inaugurates the 25th CAAC-Pharmaindustry Forum. ‘When we work together, not only do we promote research and biomedical […]